Medtronic MRI-safe lead nails CE mark; Medical scanner startup scores with crowdfunding;

 @FierceMedDev: If you missed it, here's FierceDrugDelivery's special report on the future of nanotech drug delivery. Feature | Follow @FierceMedDev

 @MarkHFierce: Is the campaign to repeal the medical device industry tax "narrow-minded and dishonest?" More | Follow @MarkHFierce

 @DamianFierce: Terumo has prevailed in patent lawsuit against Vascular Solutions. Article | Follow @DamianFierce

> Medtronic ($MDT), with CE mark in hand, plans to launch its new CapSureFix Novus lead, which can be used with an MRI when paired with a Medtronic MR-Conditional pacemaker. The company doesn't yet have U.S. approval. Release

> Mayo Clinic and Cancer Genetics launched a joint venture designed to discover and commercialize diagnostic tests that use next-generation sequencing. Item

> An activist investor wants Alere ($ALR) to sell its drug testing business and focus more on its diagnostics and services arms. Such a transaction could generate $2.5 billion, Reuters reports. Story

> Neuronetics said it has generated excellent data showing its transcranial magnetic stimulation therapy helped treat patients with depression and maintain those positive results through 12 months of treatment. Story

> Scanadu is rapidly raising money via crowdfunding to help fuel development of its Scout medical scanner, which generates data after sitting on a patient's forehead for ten seconds. Story

> Varian Medial Systems ($VAR) won an FDA 510(k) clearance for its new digital X-ray imaging system. Release

Biotech News

 @FierceBiotech: PR: Life sciences industry vet Stephane Bancel joins Flagship Ventures. Release | Follow @FierceBiotech

 @JohnCFierce: Is Novartis seriously scouting for new Alzheimer's drug candidates? More | Follow @JohnCFierce

 @RyanMFierce: John Reynders is leaving AstraZeneca for CIO gig at hot biotech startup Moderna. Release | What he's done | Follow @RyanMFierce

> VC: Kineta, Omerix gain fresh venture backing for R&D programs. News

> GlaxoSmithKline wins up to $200M federal contract to develop new antibiotics. More

> Analysts tap the next big thing in biopharma R&D. Article

Pharma News

 @FiercePharma: Amag pulls anemia drug batch after Swiss patient dies. Report | Follow @FiercePharma

 @EricPFierce: Pfizer's effort to avoid a shortage after recall of new formulation of Levoxyl backfires with second recall. Article | Follow @EricPFierce

> Merck to buy $5B in stock from Goldman Sachs in jump-start for repurchase plan. News

> Boehringer Ingelheim handed FDA warning letter. Report

> Pfizer offers share exchange to grant Zoetis its freedom. More

Drug Delivery News

 @MichaelGFierce: Nanoparticles made from grapefruit lipids deliver drugs safely. More | Follow @MichaelGFierce

> Single-cell electroporation riddles cells with drug delivery holes. Article

> Elixir bolsters recent CE mark with successful pivotal trial. News

> Radioactive nanoparticles target, shrink metastasized lymphoma tumors. Story

> Alnylam records RNAi delivery success to treat rare disease. More

> FDA clears Oramed's oral insulin pill for PhII trials. Article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.